1. Home
  2. OXSQ vs IMRX Comparison

OXSQ vs IMRX Comparison

Compare OXSQ & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OXSQ
  • IMRX
  • Stock Information
  • Founded
  • OXSQ 2003
  • IMRX 2008
  • Country
  • OXSQ United States
  • IMRX United States
  • Employees
  • OXSQ N/A
  • IMRX N/A
  • Industry
  • OXSQ Blank Checks
  • IMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • OXSQ Finance
  • IMRX Health Care
  • Exchange
  • OXSQ Nasdaq
  • IMRX Nasdaq
  • Market Cap
  • OXSQ 174.9M
  • IMRX 145.7M
  • IPO Year
  • OXSQ N/A
  • IMRX 2021
  • Fundamental
  • Price
  • OXSQ $2.30
  • IMRX $3.37
  • Analyst Decision
  • OXSQ
  • IMRX Strong Buy
  • Analyst Count
  • OXSQ 0
  • IMRX 4
  • Target Price
  • OXSQ N/A
  • IMRX $13.25
  • AVG Volume (30 Days)
  • OXSQ 568.0K
  • IMRX 695.8K
  • Earning Date
  • OXSQ 08-12-2025
  • IMRX 08-12-2025
  • Dividend Yield
  • OXSQ 18.03%
  • IMRX N/A
  • EPS Growth
  • OXSQ N/A
  • IMRX N/A
  • EPS
  • OXSQ N/A
  • IMRX N/A
  • Revenue
  • OXSQ $42,166,831.00
  • IMRX N/A
  • Revenue This Year
  • OXSQ N/A
  • IMRX N/A
  • Revenue Next Year
  • OXSQ N/A
  • IMRX N/A
  • P/E Ratio
  • OXSQ N/A
  • IMRX N/A
  • Revenue Growth
  • OXSQ N/A
  • IMRX N/A
  • 52 Week Low
  • OXSQ $2.14
  • IMRX $1.00
  • 52 Week High
  • OXSQ $3.07
  • IMRX $4.69
  • Technical
  • Relative Strength Index (RSI)
  • OXSQ 48.02
  • IMRX 43.79
  • Support Level
  • OXSQ $2.29
  • IMRX $3.42
  • Resistance Level
  • OXSQ $2.35
  • IMRX $4.69
  • Average True Range (ATR)
  • OXSQ 0.03
  • IMRX 0.31
  • MACD
  • OXSQ -0.00
  • IMRX -0.17
  • Stochastic Oscillator
  • OXSQ 11.11
  • IMRX 6.39

About OXSQ Oxford Square Capital Corp.

Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing and Diversified Insurance.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: